Full Author : ['Dagenais, Gilles R', 'Ryden, Lars', 'Leiter, Lawrence A', 'Lakshmanan, Mark', 'Dyal, Leanne', 'Probstfield, Jeffrey L', 'Atisso, Charles Messan', 'Shaw, Jonathan E', 'Conget, Ignacio', 'Cushman, William C', 'Lopez-Jaramillo, Patricio', 'Lanas, Fernando', 'Munoz, Ernesto German Cordona', 'Pirags, Valdis', 'Pogosova, Nana', 'Basile, Jan', 'Sheu, Wayne H H', 'Temelkova-Kurktschiev, Theodora', 'Raubenheimer, Peter J', 'Keltai, Matyas', 'Hall, Stephanie', 'Pais, Prem', 'Colhoun, Helen M', 'Riddle, Matthew C', 'Gerstein, Hertzel C']
Journal Title : Cardiovascular diabetology
Chapter : Section3
Journal Year : 2020
Cited by : Not Available
BACKGROUND: The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) double blind randomized trial demonstrated that weekly subcutaneous dulaglutide 1.5 mg, a glucagon like peptide-1 receptor agonist, versus matched placebo reduce.....
